Health Condition 1: E11- Type 2 diabetes mellitus
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Type 2 Diabetes Mellitus
Exclusion criteria
Exclusion criteria: • Subjects receiving: vitamin K and its inhibitors, vitamin D and calcium, steroids, anti-epileptic drugs, Calcitonin, Bisphosphonate, estrogen,thiazolidinediones. • Subjects having pancreatic gland dysfunction (example: pancreatitis, traumatic injury to pancreas), liver disorder (example: liver cirrhosis), musculoskeletal disorders (example: multiple myeloma, fracture), hypoparathyroidism and hyperparathyroidism, hypothyroidism and hyperthyroidism , ckd-mbd.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Association of serum osteocalcin with fasting insulin levels,insulin resistance(HOMA-IR) and pancreatic beta cell function(HOMA-beta) in type 2 diabetes mellitus.Timepoint: At the time of enrollment. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes will be association of serum osteocalcin in type 2 diabetes mellitus subjects with: 1.Fasting plasma glucose(FPG),post prandial plasma glucose(PPG),HbA1C. 2.Anthropometric measurements(BMI and waist/hip ratio) and fasting lipid profile. 3.Microvascular complications(retinopathy and nephropathy).Timepoint: At the time of enrollment. | — |
Countries
India
Contacts
KASTURBA MEDICAL COLLEGE